DongaST requested permission of superbacteria-targeted antibiotics
On August 29th, DongaST submitted new drug application to the Ministry of Food and Drug Safety for releasing SIVEXTRO in domestic market. SIVEXTRO(main component: Tedizolid Phosphate) is Super Bacteria-targeted antibiotics, for the first time, which is approved as a self-developed drug by U.S. FD...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
